Updated:
BlackRock Health Sciences Trust
The BlackRock Health Sciences Trust is a listed closed-end fund whose inception was shaped by the view that healthcare innovation demands a capital base...
BlackRock Health Sciences Trust
The BlackRock Health Sciences Trust is a listed closed-end fund whose inception was shaped by the view that healthcare innovation demands a capital base not subject to daily redemptions. Managed by BlackRock Advisors under the purview of its fundamental equity and systematic active equity platforms, the trust aggregates securities from biotechnology startups to mature pharmaceutical conglomerates. The portfolio also holds medical technology, life sciences tools, and healthcare provider debt, assembling a concentration of assets that regulators require to carry the 'health sciences' label. The strategy does not confine itself to a single asset class. The trust holds common stocks of drug developers and device manufacturers alongside convertible bonds and high-yield debt from healthcare issuers. Equity positions have included large-cap weightings to Eli Lilly and UnitedHealth Group alongside clinical-stage names with binary event risk. Offsetting the volatility, the trust systematically writes index and single-stock call options against portions of the portfolio, sacrificing some upside capture for monthly distributions — a structure that has defined its income profile since its launch. The fund's operational heft sits within BlackRock's broader active equity infrastructure, which embeds access to issuer management teams and scientific advisory networks. No separate employee count is reported for the trust itself, given its reliance on shared BlackRock analyst and portfolio management resources. The trust maintains no separate offices from BlackRock's primary investment hubs, and there are no disclosed philanthropic or operating-company sidecars affiliated with the vehicle. What differentiates the trust is the pairing of deep-healthcare specialization with an options-overwriting engine inside a permanent-capital closed-end wrapper. Most healthcare funds are either long-only mutual funds that cannot employ derivatives at scale, or hedge funds that gate investor capital. The BlackRock Health Sciences Trust sits in between — a liquid ticker for shareholders, but an internal portfolio that behaves more like a hybrid credit-plus-equity healthcare pool with a structural distribution commitment that drives portfolio construction as much as sector conviction does.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
—
Corporate office
—
Sector focus
Frequently asked questions
Is the BlackRock Health Sciences Trust an open-end mutual fund?
No, the BlackRock Health Sciences Trust is a closed-end fund listed on the New York Stock Exchange. Unlike open-end mutual funds that continuously issue and redeem shares at net asset value, a closed-end fund raises capital through an initial public offering and then trades intraday on an exchange at a price that can be at a premium or discount to its net asset value. This structure allows the portfolio managers to deploy leverage and hold less liquid securities without the drag of needing to meet daily redemptions.
How does the fund use options in its investment strategy?
The trust writes covered call options on a portion of its equity holdings to generate income that supports monthly distributions to shareholders. By selling call options, the fund collects premiums that effectively lower the cost basis of the underlying stocks, though this limits participation in a sharp equity rally above the option strike price. The options-overwriting component operates alongside traditional bottom-up healthcare stock-picking and fixed-income allocations.
What healthcare subsectors are represented in the portfolio?
According to the fund's regulatory disclosures and periodic fact sheets, the portfolio typically spans large-cap pharmaceuticals, growth-stage biotechnology, medical devices and diagnostics, health insurers, healthcare technology, and life-science tools companies. The trust also holds convertible bonds and high-yield debt from healthcare issuers, extending exposure beyond the common-stock universe into the capital structures of companies developing therapeutics, running provider networks, or manufacturing medical equipment.
Who makes the investment decisions for the trust?
The trust is managed by BlackRock Advisors, LLC, an indirect, wholly-owned subsidiary of BlackRock. The day-to-day portfolio oversight typically falls to the firm's fundamental active equity healthcare team and systematic active equity specialists. Unlike a standalone partnership, the named portfolio managers are BlackRock employees who draw on the firm's centralized risk analytics, trading desks, and issuer-research resources.
Does the trust disclose its distribution sources, and are they always tied to realized income?
Yes, the trust provides a 19(a) notice alongside each distribution that breaks down the source of the payout. Distributions can come from net investment income, realized capital gains, or a return of capital. During periods when the options-writing premium and dividend income do not fully cover the scheduled distribution, the fund may distribute a portion of principal, which is explicitly disclosed in the source breakdown to distinguish sustainable yield from capital replenishment.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: